S&P 500
+27.54 +1.41%
Dow Indu
+200.36 +1.22%
+78.97 +1.68%
Crude Oil
-0.26 -0.57%
+0.800 +0.07%
-0.000105 -0.01%
US Dollar
-0.016 -0.02%


33.075 +1.235 (+3.73%)

2015-10-02 15:59:20, 20 min delay

1 Day
3 Day
5 Day
1 Month
3 Month
6 Month
1 Year
Last Price33.075
Year High36.46
Year Low28.47
52wk High36.46
52wk Low27.51
Year End Close25.0793
Shares Outstanding7,362,574
% Institutional70.9
Net Change1.235
Previous Close33.080
Time2015-10-02 15:59:20
Year High Date2015-07-31
Year Low Date2015-08-24
52wk High Date2015-07-31
52wk Low Date2014-10-16
Average Volume27,285,011
Short Interest69,485,424

Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money. View our complimentary trend analysis for PFIZER (PFE) now.

First Name
Last Name

By filling out the form, you'll receive access to trend analysis, educational videos, and other trading resources from INO.com. Trend Analysis will be sent directly to your inbox.

Trader's Blog

The Three Biggest Mistakes Traders Make - Volume 1
   11 hours ago
The Two Faces Of Stock Market Volatility
   1 day ago
Weekly Futures Recap With Mike Seery
   2 days ago

Today's Financial News

Once a broadcast news division president, David Westin now goes on the air for Bloomberg

2 days ago

NEW YORK (AP) — As ABC News president in 2006, David Westin appointed Charles Gibson anchor of the network's flagship "World News." Nine years later, Gibson returned the favor. Justin Smith, chief executive of Bloomberg Media, was considering revamping the network's morning lineup when he kicked around ideas over lunch with the now-retired Gibson. When the talk turned to anchors, Gibson asked, "how willing are you to step outside the box?"

FDA approves innovative Merck drug for new use against advanced lung cancer

2 days ago

WASHINGTON (AP) — Federal health officials on Friday expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common lung cancer. Keytruda is part of a promising new class of drugs called immunotherapies, which harness the body's immune system to help fight cancer. Merck's injectable biotech drug works by blocking a protein found in certain tumors called PD-1, which inhibits the body's natural response to cancer cells.

Corn mostly lower, wheat, oats, soybeans lower on the CBOT; beef and pork higher on the CME.

2 days ago

CHICAGO (AP) — Grain futures were mostly lower Friday on the Chicago Board of Trade. Beef and pork rose on the Chicago Mercantile Exchange. December live cattle was up 1.37 cents to $1.3137 a pound; November feeder cattle gained 2.40 cents to $1.7452 a pound; while December lean hogs added .85 cent to $.6537 a pound.

Punitive damages possible in woman's suit against DuPont claiming cancer over river dumping

2 days ago

COLUMBUS, Ohio (AP) — A federal judge on Thursday ruled against a motion by DuPont and said punitive damages were possible for an Ohio woman who says she got kidney cancer after drinking water contaminated by a chemical discharged from a company plant. The case continued after U.S. District Judge Edmund Sargus Jr. said Thursday that a "reasonable jury" could have enough evidence to find in favor of punitive damages for plaintiff Clara Bartlett, The Columbus Dispatch (http://bit.ly/1L1Hyep ) reported. DuPont had contended the evidence doesn't support the awarding of punitive damages. Sargus previously refused DuPont's request to dismiss the case.

INO.com on Facebook INO.com MarketClub on Twitter INO.com on Google+ INO.com YouTube

© Copyright INO.com, Inc. All Rights Reserved.